India · Delayed Price · Currency is INR Onyx Biotec Statistics
Total Valuation
Onyx Biotec has a market cap or net worth of INR 663.64 million. The enterprise value is 774.98 million.
| Market Cap | 663.64M |
| Enterprise Value | 774.98M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Onyx Biotec has 18.13 million shares outstanding. The number of shares has increased by 19.26% in one year.
| Current Share Class | 18.13M |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | +19.26% |
| Shares Change (QoQ) | -1.59% |
| Owned by Insiders (%) | 65.89% |
| Owned by Institutions (%) | n/a |
| Float | 5.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.96 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | 22.81 |
| EV / EBIT | 224.50 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.58 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 4.47 |
| Debt / FCF | -2.34 |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -0.39% and return on invested capital (ROIC) is 0.52%.
| Return on Equity (ROE) | -0.39% |
| Return on Assets (ROA) | 0.23% |
| Return on Invested Capital (ROIC) | 0.52% |
| Return on Capital Employed (ROCE) | 0.55% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.95M |
| Profits Per Employee | -6,006 |
| Employee Count | 357 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 3.43 |
Taxes
| Income Tax | -2.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.34% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.34% |
| 50-Day Moving Average | 34.71 |
| 200-Day Moving Average | 39.16 |
| Relative Strength Index (RSI) | 48.84 |
| Average Volume (20 Days) | 107,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Biotec had revenue of INR 694.69 million and -2.14 million in losses. Loss per share was -0.12.
| Revenue | 694.69M |
| Gross Profit | 178.17M |
| Operating Income | 3.45M |
| Pretax Income | -4.22M |
| Net Income | -2.14M |
| EBITDA | 33.97M |
| EBIT | 3.45M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 40.37 million in cash and 151.71 million in debt, with a net cash position of -111.34 million or -6.14 per share.
| Cash & Cash Equivalents | 40.37M |
| Total Debt | 151.71M |
| Net Cash | -111.34M |
| Net Cash Per Share | -6.14 |
| Equity (Book Value) | 554.08M |
| Book Value Per Share | 31.26 |
| Working Capital | 187.51M |
Cash Flow
In the last 12 months, operating cash flow was -14.94 million and capital expenditures -49.87 million, giving a free cash flow of -64.81 million.
| Operating Cash Flow | -14.94M |
| Capital Expenditures | -49.87M |
| Depreciation & Amortization | 30.52M |
| Net Borrowing | 27.14M |
| Free Cash Flow | -64.81M |
| FCF Per Share | -3.57 |
Margins
Gross margin is 25.65%, with operating and profit margins of 0.50% and -0.31%.
| Gross Margin | 25.65% |
| Operating Margin | 0.50% |
| Pretax Margin | -0.61% |
| Profit Margin | -0.31% |
| EBITDA Margin | 4.89% |
| EBIT Margin | 0.50% |
| FCF Margin | n/a |
Dividends & Yields
Onyx Biotec does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.26% |
| Shareholder Yield | -19.26% |
| Earnings Yield | -0.32% |
| FCF Yield | -9.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |